Innovative Industrial Properties Targets 26% Life Science Revenue Mix Following Q3 Expansion
Innovative Industrial Properties (IIPR) reported significant execution during the third quarter, driven by aggressive expansion into the life sciences sector and robust leasing activity across its existing portfolio. The company aims to increase its life science revenue contribution to approximately 26% of annualized income once current funding initiatives are fully realized. The strategic shift toward life sciences is supported by strong yields, including a notable 15.8% yield from the Alewife Park asset. This diversification strategy is intended to bolster long-term income stability and capitalize on high-growth specialized real estate segments.
Tickers: $IIPR
Topics: earnings leasing activity life science investments real estate
Read the full article at Seeking Alpha
Part of the story Innovative Industrial Diversifies into Life Sciences with $245 Million Financing Commitment (2 articles)